Skip to main content
Presentation
Validation of Acute Myocardial Infarction (AMI) in the FDA’s Mini-Sentinel Distributed Database
UMass Center for Clinical and Translational Science Research Retreat
  • Sarah L Cutrona, University of Massachusetts Medical School
  • Darren Toh, Harvard Pilgrim Health Care Institute, Boston
  • Aarthi Iyer, Harvard Pilgrim Health Care Institute, Boston
  • Sarah Foy, University of Massachusetts Medical School
  • Elizabeth Cavagnaro, Harvard Pilgrim Health Care Institute, Boston
  • Susan Forrow, Harvard Pilgrim Health Care Institute, Boston
  • Robert J. Goldberg, University of Massachusetts Medical School
  • Jerry H. Gurwitz, University of Massachusetts Medical School
Start Date
20-5-2011 5:00 PM
End Date
20-5-2011 7:00 PM
Disciplines
Description

The Food and Drug Administration’s (FDA) Mini-Sentinel is a pilot program that aims to conduct active surveillance to detect and refine safety signals that emerge for marketed medical products.

The purpose of this Mini-Sentinel AMI Validation project was to:

(a) develop and design an abstraction and adjudication process to use when full text medical record review is required to confirm a coded diagnosis; and

(b) to test this approach by validating a code algorithm for acute myocardial infarction (AMI).

Creative Commons License
Creative Commons Attribution-Noncommercial-Share Alike 3.0
Citation Information
Sarah L Cutrona, Darren Toh, Aarthi Iyer, Sarah Foy, et al.. "Validation of Acute Myocardial Infarction (AMI) in the FDA’s Mini-Sentinel Distributed Database" (2011)
Available at: http://works.bepress.com/sarah_cutrona/11/